The Active Pharmaceutical Ingredients Directory contains more than 5,000 API pharmaceutical companies and 25,000 executives working in the API industry around the world. Published annually and updated ...

LUXEMBOURG, March 26, 2020 /PRNewswire/ -- C 2 PHARMA s.a.r.l. (C2P), a Luxembourg-based phytochemical and chemical pharmaceutical manufacturing and distribution group, is announcing that they will ...

The traditional APIs segment accounted for the largest share in 2024, whereas the HPAPI segment is expected to grow at the fastest CAGR over the forecast period. The HPAPI segment is further segmented ...

Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into ...

Aoxing Pharmaceutical (NYSE Amex: AXN) ("Aoxing Pharma"), a specialty pharmaceutical company focusing on research, development, manufacturing and distribution of narcotic and pain-management products, ...

Teva Pharmaceuticals is having issues with its active pharmaceutical ingredient (API) plant in Italy serious enough that it has had to stop production. The Israeli drugmaker sent a “Dear Customer” ...

Recipharm is pleased to announce that it has signed an agreement with Daewoong, the leading Korean based pharmaceutical company with a strong presence in respiratory therapeutics, for a ten year ...

The Indian Active Pharmaceutical Ingredients (API) market in 2025 was valued at US$14.2 billion and is expected to grow at a CAGR of 8.5% to reach US$21.46 billion by 2030. In contrast, the global ...

Javascript is required for you to be able to read premium content. Please enable it in your browser settings.